1 not yet recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow RVU120: new trials by email Literature Review of RVU120 trials Research Report on RVU120
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CDK8 Inhibitor RVU120 in Combination With Everolimus in Children With Recurrent or Progressive Group 3 or 4 Medulloblastoma RVU120, Everolimus (Afinitor) tablets - Medulloblastoma Recurrent, Medulloblastoma | Phase 1 | Not yet recruiting | Bożenna Dembowska Bagińska | 48 | 2026-09-01 | 2026-10-08 |
| RVU120 (SEL120) in Patients With Relapse/Refractory Metastatic or Advanced Solid Tumors RVU120 - Advanced Solid Tumor | Phase 1 / Phase 2 | Terminated | Ryvu Therapeutics SA | 66 | 2021-08-13 | 2026-09-18 |
Recurrence (2) · Medulloblastoma (1) · Neoplasm Metastasis (1)
Bożenna Dembowska Bagińska (1) · Ryvu Therapeutics SA (1)
Poland (2) · Spain (1)